Kathryn E. Wengel - 14 Feb 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Chief GSC Officer
Signature
Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel
Issuer symbol
JNJ
Transactions as of
14 Feb 2022
Net transactions value
-$117,351
Form type
4
Filing time
15 Feb 2022, 19:03:50 UTC
Previous filing
15 Feb 2022
Next filing
29 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +1,896 +2.9% $0.000000 66,319 14 Feb 2022 Direct F1
transaction JNJ Common Stock Tax liability $117,351 -695 -1% $168.85 65,624 14 Feb 2022 Direct F2
holding JNJ Common Stock 46 14 Feb 2022 By 401k F3
holding JNJ Common Stock 281 14 Feb 2022 By ESOP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -1,896 -100% $0.000000* 0 14 Feb 2022 Common Stock 1,896 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).
F4 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).